Swiss firms invest $27 billion in US after tariff deal, NZZ am Sonntag reports - Finance news and analysis from Global Banking & Finance Review
Finance

Swiss firms invest $27 billion in US after tariff deal, NZZ am Sonntag reports

Published by Global Banking & Finance Review

Posted on June 7, 2026

2 min read

· Last updated: June 7, 2026

Add as preferred source on Google

Swiss Companies Invest $27 Billion in US After Tariff Agreement Signed

Surge in Swiss Investment Following US Tariff Deal

ZURICH, June 7 (Reuters) - Swiss companies invested $27 billion in the United States between January and April, as Switzerland moves to fulfil a pledge to sharply increase investment following a tariff agreement with Washington, NZZ am Sonntag reported.

The figure was contained in an internal email from the Swiss-American Chamber of Commerce to its members seen by the newspaper, it said.

Background of the Investment Pledge

• Switzerland and the U.S. said on November 14 that Swiss companies would invest $200 billion in the U.S. over the next five years. The pledge formed part of a preliminary agreement under which U.S. President Donald Trump reduced punitive tariffs on Swiss goods to 15% from 39%, after imposing the higher rate at the beginning of August.

Major Swiss Investors and Projects

• The investors include Novartis which has announced two U.S. projects, including a biomedical research centre in San Diego and a cancer-drug production facility in Texas, while Roche is expanding output in North Carolina. Medical technology company Ypsomed is building a new factory in the state.

Other Notable Investments

• Other investments include shipping group MSC's new North American headquarters in Miami. The newspaper said this also covers spending on cruise and logistics operations.

• Industrial companies including machine tool maker Pfiffner Group and electronics firm Elma are expanding U.S. production capacity.

Statements from Swiss-American Chamber of Commerce

• "We are model students and we fulfil our promises," Swiss Amcham Chief Executive Rahul Sahgal was quoted as saying.

Recent US Tariff Measures

• Washington this week announced new tariffs against countries it says are not doing enough to combat forced labour.

• The U.S. plans a 12.5% tariff on Swiss goods under that measure, compared with 10% for EU goods, the newspaper said.

(Reporting by John Revill, Editing by William Maclean)

Key Takeaways

  • Swiss companies invested $27 billion in the U.S. from Jan–Apr, per NZZ am Sonntag and Reuters.
  • This surge ties to a 5‑year, $200 billion Swiss investment pledge linked to tariff relief agreements.
  • Novartis is undertaking transformative U.S. projects—including a $1.1 billion biomedical research center in San Diego—as part of a broader $23 billion U.S. investment program; meanwhile, U.S. tariffs under Section 301 may impose a 12.5 % rate on Swiss goods pending consultation.

Frequently Asked Questions

How much have Swiss companies recently invested in the United States?
Swiss companies invested $27 billion in the US between January and April, according to a report by NZZ am Sonntag.
What triggered the surge in Swiss investment in the US?
The investment surge followed a tariff agreement between Switzerland and the US, where punitive tariffs on Swiss goods were reduced from 39% to 15%.
Which Swiss companies are leading investments in the US?
Novartis, Roche, Ypsomed, MSC, Pfiffner Group, and Elma are among the Swiss firms making significant US investments.
What is the investment commitment made by Swiss companies to the US?
Swiss companies pledged to invest $200 billion in the US over the next five years as part of the tariff deal.
What industries are Swiss companies investing in within the US?
Swiss investments cover sectors like pharmaceuticals, medical technology, shipping, logistics, machine tools, and electronics.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category